Fully printed and self-compensated bioresorbable electrochemical devices based on galvanic coupling for continuous glucose monitoring.
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
21 07 2023
21 07 2023
Historique:
medline:
21
7
2023
pubmed:
19
7
2023
entrez:
19
7
2023
Statut:
ppublish
Résumé
Real-time glucose monitoring conventionally involves non-bioresorbable semi-implantable glucose sensors, causing infection and pain during removal. Despite bioresorbable electronics serves as excellent alternatives, the bioresorbable sensor dissolves in aqueous environments with interferential biomolecules. Here, the theories to achieve stable electrode potential and accurate electrochemical detection using bioresorbable materials have been proposed, resulting in a fully printed bioresorbable electrochemical device. The adverse effect caused by material degradation has been overcome by a molybdenum-tungsten reference electrode that offers stable potential through galvanic-coupling and self-compensation modules. In vitro and in vivo glucose monitoring has been conducted for 7 and 5 days, respectively, followed by full degradation within 2 months. The device offers a glucose detection range of 0 to 25 millimolars and a sensitivity of 0.2458 microamperes per millimolar with anti-interference capability and biocompatibility, indicating the possibility of mass manufacturing high-performance bioresorbable electrochemical devices using printing and low-temperature water-sintering techniques. The mechanisms may be implemented developing more comprehensive bioresorbable sensors for chronic diseases.
Identifiants
pubmed: 37467335
doi: 10.1126/sciadv.adi3839
pmc: PMC10355816
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
eadi3839Références
Nature. 2016 Feb 4;530(7588):71-6
pubmed: 26779949
Nat Commun. 2020 Nov 25;11(1):5990
pubmed: 33239608
Biosens Bioelectron. 2017 May 15;91:885-891
pubmed: 28167366
Diabetes Care. 2014;37(1):9-16
pubmed: 24356592
Proc Natl Acad Sci U S A. 2021 Jul 13;118(28):
pubmed: 34260393
Front Chem. 2021 Jul 29;9:723186
pubmed: 34395386
Biosens Bioelectron. 2022 Jun 15;206:114123
pubmed: 35259608
Adv Mater. 2022 Apr;34(14):e2108203
pubmed: 35073597
Nat Biomed Eng. 2018 Dec;2(12):894-906
pubmed: 30931173
RSC Adv. 2021 Jun 8;11(33):20550-20556
pubmed: 35479878
Anal Chim Acta. 2007 Jan 2;581(1):7-12
pubmed: 17386418
Microsyst Nanoeng. 2021 Sep 29;7:75
pubmed: 34631143
ACS Omega. 2019 Oct 21;4(19):18312-18316
pubmed: 31720532
Talanta. 2022 Nov 1;249:123695
pubmed: 35728453
Biosens Bioelectron. 2020 Jul 15;160:112220
pubmed: 32339151
Nat Commun. 2020 Jun 25;11(1):3207
pubmed: 32587309
Biosens Bioelectron. 2019 Oct 15;143:111622
pubmed: 31470172
Anal Chem. 2019 Mar 19;91(6):3778-3783
pubmed: 30773009
Adv Mater. 2020 Jan;32(3):e1806478
pubmed: 31116898
Sensors (Basel). 2017 Aug 12;17(8):
pubmed: 28805693
Diabetes Technol Ther. 2017 May;19(S2):S4-S11
pubmed: 28541137
Diabetes Care. 2020 Jan;43(1):e3-e4
pubmed: 31558548
Anal Sci. 2011;27(4):375
pubmed: 21478612
Sci Adv. 2021 Jan 27;7(5):
pubmed: 33571117
Biomed Microdevices. 2018 Dec 6;20(4):101
pubmed: 30523421
Sci Rep. 2016 Feb 15;6:21009
pubmed: 26876368
SLAS Technol. 2019 Oct;24(5):499-505
pubmed: 31063700
Biosens Bioelectron. 2020 Oct 1;165:112408
pubmed: 32729528
Sci Adv. 2022 Oct 7;8(40):eabp9169
pubmed: 36197971
Biosens Bioelectron. 2022 May 1;203:114026
pubmed: 35114468
Diabetes Care. 2015 Dec;38(12):2354-69
pubmed: 26604281